Search details
1.
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Lancet Oncol
; 25(3): 388-399, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38423051
2.
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.
BJU Int
; 131 Suppl 4: 14-22, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36594205
3.
Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.
BJU Int
; 131 Suppl 4: 6-13, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36495481
4.
Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.
BJU Int
; 131 Suppl 4: 23-31, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36495482
5.
Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.
BJU Int
; 131(5): 588-595, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36371669
6.
A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia.
Invest New Drugs
; 40(4): 773-781, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35579731
7.
Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia.
Haematologica
; 107(11): 2641-2649, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-35511672
8.
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
BMC Urol
; 22(1): 28, 2022 Mar 02.
Article
in English
| MEDLINE | ID: mdl-35236338
9.
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.
Blood
; 141(12): 1489-1493, 2023 03 23.
Article
in English
| MEDLINE | ID: mdl-36493344
10.
Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
BJU Int
; 125(3): 369-378, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31725935
11.
Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation.
BMC Urol
; 20(1): 81, 2020 Jul 01.
Article
in English
| MEDLINE | ID: mdl-32611411
12.
Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
Oncologist
; 24(9): 1253-1258, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30944185
13.
Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI.
BJU Int
; 124 Suppl 1: 42-49, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31287613
14.
Focal irreversible electroporation as primary treatment for localized prostate cancer.
BJU Int
; 121(5): 716-724, 2018 05.
Article
in English
| MEDLINE | ID: mdl-28796935
15.
Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy.
World J Urol
; 36(9): 1383-1389, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29594551
16.
Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy.
Bioorg Med Chem Lett
; 28(15): 2655-2659, 2018 08 15.
Article
in English
| MEDLINE | ID: mdl-29935771
17.
Mito-protective autophagy is impaired in erythroid cells of aged mtDNA-mutator mice.
Blood
; 125(1): 162-74, 2015 Jan 01.
Article
in English
| MEDLINE | ID: mdl-25411424
18.
A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.
BJU Int
; 120(6): 774-781, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28207981
19.
Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
BJU Int
; 120 Suppl 3: 51-58, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28834167
20.
Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib.
Transfusion
; 56(4): 970-4, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26779871